Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo

Molecular Therapy

Volumn 10, Issue 1, 2004, Pages 67-75

  Puskovic, Veljko ^a   Wolfe, Darren ^a   Goss, James ^a,b   Huang, Shaohua ^a   Mata, Marina ^a,b   Glorioso, Joseph C ^a   Fink, David J ^c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

6 hydroxydopamine; Gene therapy; Glial cell derived neurotrophic factor; Herpes simplex virus; Latency; Mouse; MPTP; Parkinson disease; Rat

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE TRANSPORTER; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; OXIDOPAMINE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; INOCULATION; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SUBSTANTIA NIGRA; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MICE; NERVE GROWTH FACTORS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; PROMOTER REGIONS (GENETICS); RATS; SIMPLEXVIRUS; TRANSGENES;

SIMPLEXVIRUS;

EID: 3042856075     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.04.004     Document Type: Article

References (53)

1. Efstathiou S. Minson A.C. Field H.J. Anderson J.R. Wildy P. Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans J. Virol. 57 1986 446-455
2. Ramakrishnan R. Poliani P.L. Levine M. Glorioso J.C. Fink D.J. Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR J. Virol. 70 1996 6519-6523
3. Rock D.L. Fraser N.W. Detection of HSV-1 genome in central nervous system of latently infected mice Nature 302 1983 523-525
4. Ramakrishnan R. Levine M. Fink D.J. PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant J. Virol. 68 1994 7083-7091
5. Goins W.F. Krisky D. Wolfe D.P. Fink D.J. Glorioso J. Development of herpes simplex virus replication defective vectors Morgan J. (Ed.). Gene Therapy Protocols: Methods in Molecular Medicine 2001 Humana Press Clifton, NJ
6. Yamada M. et al. Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion Exp. Neurol. 168 2001 225-230
7. Natsume A. et al. Enhanced functional recovery after proximal nerve root injury by vector-mediated gene transfer Exp. Neurol. 184 2003 878-886
8. Chattopadhyay M. et al. In vivo gene therapy of pyridoxine-induced neuropathy by HSV-mediated gene transfer of neurotrophin-3 Ann. Neurol. 51 2002 19-27
9. Chattopadhyay M. et al. Protective effect of HSV-mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals Eur. J. Neurosci. 17 2003 732-740
10. Goss J.R. Mata M. Goins W.F. Wu H.H. Glorioso J.C. Fink D.J. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion Gene Ther. 8 2001 551-556
11. Hao S. Mata M. Goins W. Glorioso J.C. Fink D.J. Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect Pain 102 2003 135-142
12. Wilson S.P. Yeomans D.C. Bender M.A. Lu Y. Goins W.F. Glorioso J.C. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus Proc. Natl. Acad. Sci. USA 96 1999 3211-3216
13. Stevens J.G. Wagner E.K. Devi-Rao G.B. Cook M.L. Feldman L.T. RNA complementary to a herpesvirus a gene mRNA is prominent in latently infected neurons Science 235 1987 1056-1059
14. Croen K.D. Ostrove J.M. Dragovic L.J. Smialek J.E. Strauss S.E. Latent herpes simplex virus in human trigeminal ganglia: detection of an immediate early gene "anti-sense" transcript by in situ hybridization N. Engl. J. Med. 317 1987 1427-1432
15. Devi-Rao G.B. Goodart S.A. Hecht L.M. Rochford R. Rice M.K. Wagner E.K. Relationship between polyadenylated and nonpolyadenylated herpes simplex virus type 1 latency-associated transcripts J. Virol. 65 1991 2179-2190
16. Farrell M.J. Dobson A.T. Feldman L.T. Herpes simplex virus latency associated transcript is a stable intron Proc. Natl. Acad. Sci. USA 88 1991 790-794
17. Zwaagstra J. Ghiasi H. Nesburn A.B. Wechsler S.L. In vitro promoter activity associated with the latency-associated transcript gene of herpes simplex virus type 1 J. Gen. Virol. 70 1989 2163-2169
18. Dobson A.T. et al. Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant HSV J. Virol. 63 1989 3844-3851
19. Batchelor A.H. O'Hare P. Regulation and cell-type specific activity of a promoter located upstream of the latency-associated transcript of herpes simplex virus type I J. Virol. 64 1990 3269-3279
20. Goins W.F. et al. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats J. Virol. 68 1994 2239-2252
21. Chen X. Schmidt M.C. Goins W.F. Glorioso J.C. Two herpes simplex virus type 1 latency-active promoters differ in their contributions to latency-associated transcript during lytic and latent infection J. Virol. 69 1995 7897-7908
22. Lokensgard J.R. Berthomme H. Feldman L.T. The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency J. Virol. 71 1997 6714-6719
23. Smith C. Lachmann R.H. Efstathiou S. Expression from the herpes simplex virus type 1 latency-associated promoter in the murine central nervous system J. Gen. Virol. 81 2000 649-662
24. Marshall K.R. Lachmann R.H. Efstathiou S. Rinaldi A. Preston C.M. Long-term transgene expression in mice infected with a herpes simplex virus type 1 mutant severely impaired for immediate-early gene expression J. Virol. 74 2000 956-964
25. Scarpini C.G. et al. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors Gene Ther. 8 2001 1057-1071
26. Dauer W. Przedborski S. Parkinson's disease: mechanisms and models Neuron 39 2003 889-909
27. Burton E.A. Glorioso J.C. Fink D.J. Gene therapy progress and prospects: Parkinson's disease Gene Ther. 10 2003 1721-1727
28. Natsume A. et al. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA induced degeneration Exp. Neurol. 169 2001 231-238
29. Grondin R. et al. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys Brain 125 2002 2191-2201
30. Kordower J.H. et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease Science 290 2000 767-773
31. Kirik D. Rosenblad C. Bjorklund A. Mandel R.J. Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system J. Neurosci. 20 2000 4686-4700
32. Wagner E. et al. Physical characterization of the herpes simplex virus latency-associated transcript in neurons J. Virol. 62 1988 1194-1202
33. Wechsler S.L. Nesburn J. Zwaagstra N. Ghiasi H. Sequence of the latency related gene of herpes simplex virus type 1 Virology 168 1989 168-172
34. Goins W.F. et al. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction J. Urol. 165 2001 1748-1754
35. Margolis T.P. Bloom D.C. Dobson A.T. Feldman L.T. Stevens J.G. Decreased reporter gene expression during latent infection with HSV LAT promoter constructs Virology 197 1993 585-592
36. Lachmann R.H. Efstathiou S. Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system J. Virol. 71 1997 3197-3207
37. Jing S. et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF Cell 85 1996 1113-1124
38. Cik M. et al. Binding of GDNF and neurturin to human GDNF family receptor alpha 1 and 2: influence of cRET and cooperative interactions J. Biol. Chem. 275 2000 27505-27512
39. Ai Y. et al. Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects J. Comp. Neurol. 461 2003 250-261
40. Gill S.S. et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease Nat. Med. 9 2003 589-595
41. Johnson P.A. Yoshida K. Gage F.H. Friedmann T. Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector Brain Res. 12 1992 95-102
42. Fink D.J. DeLuca N.A. Goins W.F. Glorioso J.C. Gene transfer to neurons using herpes simplex virus-based vectors Annu. Rev. Neurosci. 19 1996 265-287
43. Shering A.F. et al. Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors J. Gen. Virol. 78 Pt 2 1997 445-459
44. Ozuer A. et al. Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors Biotechnol. Prog. 18 2002 476-482
45. Ozuer A. Wechuck J.B. Goins W.F. Wolfe D. Glorioso J.C. Ataai M.M. Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors Biotechnol. Bioeng. 77 2002 685-692
46. Markert J.M. Parker J.N. Gillespie G.Y. Whitley R.J. Genetically engineered human herpes simplex virus in the treatment of brain tumours Herpes 8 2001 17-22
47. Yeung S.N. Tufaro F. Replicating herpes simplex virus vectors for cancer gene therapy Expert Opin. Pharmacother. 1 2000 623-631
48. Krisky D.M. Marconi P.C. Oligino T. Rouse R.J. Fink D.J. Glorioso J.C. Rapid method for construction of recombinant HSV gene transfer vectors Gene Ther. 4 1997 1120-1125
49. Paxinos G. Watson C. The Rat Brain in Stereotaxic Coordinates 1982 Academic Press New York
50. Sauer H. Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat Neuroscience 59 1994 401-415
51. Montoya C.P. Campbell-Hope L.J. Pemberton K.D. Dunnett S.B. The "staircase test": a measure of independent forelimb reaching and grasping abilities in rats J. Neurosci. Methods 36 1991 219-228
52. Abrous D.N. Wareham A.T. Torres E.M. Dunnett S.B. Unilateral dopamine lesions in neonatal, weanling and adult rats: comparison of rotation and reaching deficits Behav. Brain Res. 51 1992 67-75
53. Baird A.L. Meldrum A. Dunnett S.B. The staircase test of skilled reaching in mice Brain Res. Bull. 54 2001 243-250